"Tuberculosis, Pulmonary/drug therapy"[MAJR] - Search Results

Year	Number of Results
1948	4
1949	1
1954	1
1957	1
1964	8
1965	192
1966	282
1967	251
1968	294
1969	263
1970	278
1971	244
1972	249
1973	215
1974	202
1975	133
1976	139
1977	108
1978	125
1979	128
1980	141
1981	112
1982	97
1983	133
1984	110
1985	106
1986	108
1987	108
1988	100
1989	104
1990	107
1991	83
1992	64
1993	79
1994	76
1995	92
1996	98
1997	88
1998	121
1999	111
2000	103
2001	101
2002	134
2003	183
2004	159
2005	124
2006	161
2007	157
2008	158
2009	155
2010	142
2011	144
2012	185
2013	189
2014	197
2015	214
2016	204
2017	204
2018	165
2019	148
2020	175
2021	200
2022	195
2023	177
2024	203
2025	129

1

Micronutrient Deficiency in Pulmonary Tuberculosis - Perspective on Hepatic Drug Metabolism and Pharmacokinetic Variability of First-line Anti- Tuberculosis Drugs: Special Reference to Fat-soluble Vitamins A, D, & E and Nutri-epigenetics.

Jeyakumar SM. Jeyakumar SM. Drug Metab Lett. 2021;14(3):166-176. doi: 10.2174/1872312814999211130093625. Drug Metab Lett. 2021. PMID: 34847853 Review.

2

Dzherelo (Immunoxel) as adjunctive therapy to standard antituberculosis treatment in patients with pulmonary tuberculosis: a systematic review and meta-analysis of clinical trials.

Kitenge M, Phiri B, Pheeha SM, Ogunrombi M, Nyasulu PS. Kitenge M, et al. Syst Rev. 2021 May 26;10(1):157. doi: 10.1186/s13643-021-01698-2. Syst Rev. 2021. PMID: 34039420 Free PMC article.

3

Analysis of the effect of anti-tuberculosis therapy combined with all-in-one nursing care on the alleviation of inflammation in patients with pulmonary tuberculosis.

Liu A, Yin X, Wang R, Cheng L, Zhang Y, Tu F, Ma J, Zhong Y. Liu A, et al. Cell Mol Biol (Noisy-le-grand). 2023 Jan 31;69(1):131-136. doi: 10.14715/cmb/2022.69.1.23. Cell Mol Biol (Noisy-le-grand). 2023. PMID: 37213145 Clinical Trial.

4

General considerations in intermittent drug therapy of pulmonary tuberculosis.

Fox W. Fox W. Postgrad Med J. 1971 Nov;47(553):729-36. doi: 10.1136/pgmj.47.553.729. Postgrad Med J. 1971. PMID: 4110537 Free PMC article. Review.

5

Inhalable nanoparticles delivery targeting alveolar macrophages for the treatment of pulmonary tuberculosis.

Chae J, Choi Y, Tanaka M, Choi J. Chae J, et al. J Biosci Bioeng. 2021 Dec;132(6):543-551. doi: 10.1016/j.jbiosc.2021.08.009. Epub 2021 Sep 15. J Biosci Bioeng. 2021. PMID: 34538591 Review.

6

Control of tuberculosis.

Mitchell RS. Mitchell RS. N Engl J Med. 1967 Apr 20;276(16):905-11 contd. doi: 10.1056/NEJM196704202761606. N Engl J Med. 1967. PMID: 5336071 Review. No abstract available.

7

Cavitary pulmonary tuberculosis during treatment with guselkumab.

Cerejeira A, Canelas G, Vide J, Duro R, Azevedo F, Magina S. Cerejeira A, et al. J Eur Acad Dermatol Venereol. 2022 Jun;36(6):e488-e490. doi: 10.1111/jdv.17992. Epub 2022 Feb 17. J Eur Acad Dermatol Venereol. 2022. PMID: 35138650 No abstract available.

8

Tuberculosis--chemotherapy.

Citron KM. Citron KM. Br Med J. 1972 Feb 12;1(5797):426-8. doi: 10.1136/bmj.1.5797.426. Br Med J. 1972. PMID: 4109997 Free PMC article. Review. No abstract available.

9

Tuberculosis chemotherapy today.

Dutt AK, Stead WW. Dutt AK, et al. Ann Acad Med Singap. 1985 Jul;14(3):508-14. Ann Acad Med Singap. 1985. PMID: 3935036 Review.

10

Tuberculosis.

Garner P, Holmes A. Garner P, et al. West J Med. 1999 Jul;171(1):37-40. West J Med. 1999. PMID: 10483345 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,171 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,171 results

Results by year